KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash & Equivalents: 2019-2024

Historic Cash & Equivalents for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $561.6 million.

  • Ginkgo Bioworks Holdings' Cash & Equivalents fell 81.98% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.1 million, marking a year-over-year decrease of 81.98%. This contributed to the annual value of $561.6 million for FY2024, which is 40.52% down from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Cash & Equivalents stood at $561.6 million, which was down 40.52% from $944.1 million recorded in FY2023.
  • In the past 5 years, Ginkgo Bioworks Holdings' Cash & Equivalents registered a high of $1.6 billion during FY2021, and its lowest value of $380.8 million during FY2020.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Cash & Equivalents value was $944.1 million (recorded in 2023), while the average stood at $940.5 million.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Cash & Equivalents skyrocketed by 307.04% in 2021 and then crashed by 40.52% in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Cash & Equivalents (Yearly) stood at $380.8 million in 2020, then surged by 307.04% to $1.6 billion in 2021, then dropped by 15.11% to $1.3 billion in 2022, then decreased by 28.25% to $944.1 million in 2023, then crashed by 40.52% to $561.6 million in 2024.